Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL4796024 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL6501209 | 0.95 | — | — | |
| SCHEMBL2335211 | 0.95 | TSHR (0.58) | — | |
| SCHEMBL14994799 | 0.95 | TSHR (0.58) | — | |
| SCHEMBL16959 | 0.95 | — | — | |
| Methane SCHEMBL25267970 | 0.90 | — | — | |
| SCHEMBL11418802 | 0.90 | TSHR (0.54) | — | |
| Hydrochloric Acid SCHEMBL137610 | 0.90 | — | — | |
| SCHEMBL5899501 | 0.90 | — | — | |
| SCHEMBL7456233 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4554555-A1 | COMPOSITION COMPRISING AN EXTRACT OF JASMINUM SAMBAC AND USE THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2025-05-21 | — | — | EP | claimed |
| CN-119486710-A | Composition comprising jasmine extract and use thereof | 科莱恩国际有限公司 | 2025-02-18 | — | — | CN | claimed |
| EP-4376807-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING COMBINATION OF SGLT2 INHIBITOR AND DPP-IV INHIBITOR | Unison Pharmaceuticals Pvt. Ltd. (IN) | 2024-06-05 | — | — | EP | claimed |
| WO-2024012787-A1 | COMPOSITION COMPRISING AN EXTRACT OF JASMINUM SAMBAC AND USE THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2024-01-18 | — | — | WO | claimed |
| WO-2023007511-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING COMBINATION OF SGLT2 INHIBITOR AND DPP-IV INHIBITOR | UNISON PHARMACEUTICALS PVT. LTD. (IN) | 2023-02-02 | — | — | WO | claimed |
| WO-2021260617-A1 | AN IMPROVED PROCESS FOR PREPARATION OF DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE | HIKAL LIMITED (IN) | 2021-12-30 | — | — | WO | claimed |
| US-11033544-B2 | Low-dose triple combination formulation | The George Institute for Global Health (AU) | 2021-06-15 | — | — | US | claimed |
| US-20200306246-A1 | LOW-DOSE TRIPLE COMBINATION FORMULATION | The George Institute for Global Health (AU) | 2020-10-01 | — | — | US | claimed |
| CN-109664418-A | A kind of mute type diamond fretsaw | 镇江笑宁能源科技有限公司 | 2019-04-23 | — | — | CN | claimed |
| CN-107033321-A | A kind of waterborne polyurethane resin and preparation method thereof | 合肥科天水性科技有限责任公司 | 2017-08-11 | — | — | CN | claimed |
| WO-2017118945-A1 | PREMIX OF DAPAGLIFLOZIN AND PROCESS FOR THE PREPARATION THEREOF | LUPIN LIMITED (IN) | 2017-07-13 | — | — | WO | claimed |
| CN-106928421-A | A kind of clothing leather soft bed material and preparation method thereof | 合肥科天水性科技有限责任公司 | 2017-07-07 | — | — | CN | claimed |
| EP-4739697-A1 | PROCESS FOR THE PREPARATION OF DAPAGLIFLOZIN | Zaklady Farmaceutyczne Polpharma S.A. (PL) | 2026-05-13 | — | — | EP | disclosed |
| EP-4724031-A1 | EXTRACT OF THE CYBELE VARIETY OF PUNICA GRANATUM, AND USES THEREOF IN COSMETICS | GATTEFOSSE SAS (FR) | 2026-04-15 | — | — | EP | disclosed |
| US-20260069550-A1 | TRANSDERMAL DELIVERY OF ANTIDIABETIC AGENTS | RITTENHOUSE CHRISTINE (US) | 2026-03-12 | — | — | US | disclosed |
| US-20250352458-A1 | IMPROVEMENTS IN OR RELATING TO EXTRACTS | GIVAUDAN SA (CH) | 2025-11-20 | — | — | US | disclosed |
| WO-2015063726-A1 | PROCESS FOR THE PREPARATION OF 4-BROMO-1-CHLORO-2-(4-ETHOXYBENZYL)BENZENE | RANBAXY LABORATORIES LIMITED (IN) | 2015-05-07 | — | — | WO | disclosed |
| WO-2015044849-A1 | PROCESS FOR THE PURIFICATION OF DAPAGLIFLOZIN | RANBAXY LABORATORIES LIMITED (IN) | 2015-04-02 | — | — | WO | disclosed |
| WO-2015040571-A1 | PROCESS FOR THE PREPARATION OF DAPAGLIFLOZIN | RANBAXY LABORATORIES LIMITED (IN) | 2015-03-26 | — | — | WO | disclosed |
| EP-1505057-B1 | METHOD OF PURIFYING QUATERNARY ALKYLAMMONIUM SALT | STELLA CHEMIFA KABUSHIKI KAISHA (JP) | 2011-06-22 | — | — | EP | disclosed |